Literature DB >> 12704728

Decreased viability of nitric oxide synthase double knockout mice.

Susanne Tranguch1, Yvette Huet-Hudson.   

Abstract

Nitric oxide acts as an important intracellular messenger in a variety of systems, including reproduction. Previous studies have shown the importance of nitric oxide in embryo development. NO is produced from l-arginine by the enzyme, nitric oxide synthase (NOS), which has three isoforms: endothelial (NOS3), neural (NOS1), and inducible (NOS2). We hypothesize that, because of the importance of NOS in development, at least two NOS isoforms are required in order for normal embryo development to occur. Through the generation of NOS3/NOS2, NOS3/NOS1, and NOS2/NOS1 double knockout mice, we found that while litter size remains unchanged, the expected number of generated double knockout mice varies significantly from what would be predicted by Mendelian genetics. Estrous cycles were similar for both DKO and the wild-type mice, and both groups were deemed fertile by their ability to mate with wild-type (CD-1) mice. Together, these results lead us to conclude that the lack of two NOS isoforms leads to a decreased viability in mice because of a developmental problem in the double knockout embryo. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12704728     DOI: 10.1002/mrd.10274

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  14 in total

Review 1.  Nitric oxide synthases in the pathogenesis of cardiovascular disease: lessons from genetically modified mice.

Authors:  Hiroaki Shimokawa; Masato Tsutsui
Journal:  Pflugers Arch       Date:  2010-02-24       Impact factor: 3.657

2.  Salt-sensitive splice variant of nNOS expressed in the macula densa cells.

Authors:  Deyin Lu; Yiling Fu; Arnaldo Lopez-Ruiz; Rui Zhang; Ramiro Juncos; Haifeng Liu; R Davis Manning; Luis A Juncos; Ruisheng Liu
Journal:  Am J Physiol Renal Physiol       Date:  2010-03-24

Review 3.  Nitric oxide-cyclic GMP signaling in stem cell differentiation.

Authors:  Kalpana Mujoo; Joshua S Krumenacker; Ferid Murad
Journal:  Free Radic Biol Med       Date:  2011-10-06       Impact factor: 7.376

Review 4.  S-Nitrosylation signaling regulates cellular protein interactions.

Authors:  Nadzeya V Marozkina; Benjamin Gaston
Journal:  Biochim Biophys Acta       Date:  2011-06-24

5.  Pathophysiology of hypertension in the absence of nitric oxide/cyclic GMP signaling.

Authors:  Robrecht Thoonen; Patrick Y Sips; Kenneth D Bloch; Emmanuel S Buys
Journal:  Curr Hypertens Rep       Date:  2013-02       Impact factor: 5.369

Review 6.  Nitric oxide synthases and tubal ectopic pregnancies induced by Chlamydia infection: basic and clinical insights.

Authors:  Ruijin Shao; Sean X Zhang; Birgitta Weijdegård; Shien Zou; Emil Egecioglu; Anders Norström; Mats Brännström; Håkan Billig
Journal:  Mol Hum Reprod       Date:  2010-07-20       Impact factor: 4.025

Review 7.  The effects of NOS2 gene deletion on mice expressing mutated human AbetaPP.

Authors:  Carol A Colton; Donna M Wilcock; David A Wink; Judianne Davis; William E Van Nostrand; Michael P Vitek
Journal:  J Alzheimers Dis       Date:  2008-12       Impact factor: 4.472

8.  Alternatively spliced neuronal nitric oxide synthase mediates penile erection.

Authors:  K Joseph Hurt; Sena F Sezen; Hunter C Champion; Julie K Crone; Michael A Palese; Paul L Huang; Akira Sawa; Xiaojiang Luo; Biljana Musicki; Solomon H Snyder; Arthur L Burnett
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-17       Impact factor: 11.205

9.  Preserved fertility despite erectile dysfunction in mice lacking the nitric oxide receptor.

Authors:  Dieter Groneberg; Barbara Lies; Peter König; Ronald Jäger; Andreas Friebe
Journal:  J Physiol       Date:  2012-11-05       Impact factor: 5.182

Review 10.  Nitric oxide, C-type natriuretic peptide and cGMP as regulators of endochondral ossification.

Authors:  Cristina C Teixeira; Hanga Agoston; Frank Beier
Journal:  Dev Biol       Date:  2008-05-03       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.